Calcium Channel Blocker Versus Renin–Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score‐Matched Cohort Study

Documenti analoghi

• Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population
  di: Minji Jung, et al.
  Pubblicazione: (2024)
• Screening and Diagnosis of Primary Aldosteronism in Patients Using Renin‐Angiotensin System Inhibitors
  di: Qian Wang, et al.
  Pubblicazione: (2026)
• Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
  di: Kazuomi Kario, et al.
  Pubblicazione: (2024)
• Letter to the Editor: “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes”
  di: Sabika Ayesha, et al.
  Pubblicazione: (2025)
• Kaempferol Ameliorates Renal Remodelling by Inhibiting the Renin‐Angiotensin System Cascade in Hypertensive Rats
  di: Putcharawipa Maneesai, et al.
  Pubblicazione: (2024)